DEXTROSE- dextrose monohydrate injection Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose injection is indicated as source of water and calories and may also be used as diluent for reconstitution of a powdered or liquid (up to 10 ml) drug product packaged in a vial with a 13 mm or 20 mm closure. the use of dextrose injection is contraindicated in patients with: risk summary appropriate administration of dextrose injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. animal reproduction studies have not been conducted with injectable dextrose solutions. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary there are no data on the presence of dextrose in human milk, the effects on a breastfed inf

DEXTROSE- dextrose monohydrate injection Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose injection is indicated as source of water and calories and may also be used as diluent for reconstitution of a powdered or liquid (up to 10 ml) drug product packaged in a vial with a 13 mm or 20 mm closure. the use of dextrose injection is contraindicated in patients with: risk summary appropriate administration of dextrose injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. animal reproduction studies have not been conducted with injectable dextrose solutions. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. risk summary there are no data on the presence of dextrose in human milk, the effects on a breastfed inf

ISOLYTE S IN DEXTROSE- hydrous dextrose, sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride and ma Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

isolyte s in dextrose- hydrous dextrose, sodium chloride, sodium gluconate, sodium acetate trihydrate, potassium chloride and ma

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), sodium gluconate (unii: r6q3791s76) (gluconic acid - unii:r4r8j0q44b), sodium acetate (unii: 4550k0sc9b) (acetic acid - unii:q40q9n063p), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838) - dextrose 5 g in 100 ml - this solution is indicated for use in adults as a source of electrolytes, calories and water for hydration, and as an alkalinizing agent. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

ISOLYTE P IN DEXTROSE- dextrose, sodium acetate, potassium chloride, magnesium chloride, and potassium phosphate, dibasic inject Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

isolyte p in dextrose- dextrose, sodium acetate, potassium chloride, magnesium chloride, and potassium phosphate, dibasic inject

b. braun medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium acetate (unii: 4550k0sc9b) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), potassium phosphate, dibasic (unii: ci71s98n1z) (potassium cation - unii:295o53k152, phosphate ion - unii:nk08v - dextrose monohydrate 5 g in 100 ml - this solution is indicated for use in adults as a source of electrolytes, calories and water for hydration, and as an alkalinizing agent. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

VETIVEX VETERINARY LACTATED RINGERS AND DEXTROSE- dextrose monohydrate, sodium lactate, sodium chloride, potassium chloride, and Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

vetivex veterinary lactated ringers and dextrose- dextrose monohydrate, sodium lactate, sodium chloride, potassium chloride, and

dechra veterinary products - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium lactate (unii: tu7hw0w0qt) (lactic acid, unspecified form - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn486 - dextrose monohydrate 50 mg in 1 ml - veterinary lactated ringer's and 5% dextrose injection, usp is indicated as a source of water, electrolytes and calories or as an alkalinizing agent. solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

DEXTROSE- dextrose monohydrate injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection, solution

cardinal health - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose injection, usp is indicated as a source of water and calories. solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

DEXTROSE- dextrose monohydrate injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection, solution

cardinal health - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose injection, usp is indicated as a source of water and calories. solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

DEXTROSE- dextrose monohydrate injection Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose monohydrate injection

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 2.50 g in 50 ml

DEXTROSE- dextrose injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose- dextrose injection, solution

vedco - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 50 g in 100 ml - for use as an aid in the treatment of acetonemia (ketosis) in cattle. for animal use only

DEXTROSE injection, solution Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dextrose injection, solution

general injectables & vaccines, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 25 g in 50 ml - 50% dextrose injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. the solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. slow infusion of hypertonic solutions is essential to insure proper utilization of dextrose and avoid production of hyperglycemia. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.